Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James E. Dentzer currently holds 3,318 shares of AMICUS THERAPEUTICS INC (FOLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James E. Dentzer has been a net seller of FOLD stock. They have purchased $0 and sold $92.4K worth of shares.
James E. Dentzer's most recent insider trade was on Aug 4, 2025, when they sold 3,318 shares at $9.20 per share.
James E. Dentzer serves as Executive at AMICUS THERAPEUTICS INC (FOLD). They have executed 40 insider transactions totaling $92.4K over their tenure at the company.
James E. Dentzer holds the position of Executive at AMICUS THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
James E. Dentzer has shown a selling trading pattern, with $0 in total purchases and $92.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James E. Dentzer was on May 21, 2024, when they purchased $1.2M worth of CRIS shares. This transaction involved 100,000 shares at $11.62 per share.
James E. Dentzer currently owns 3,318 shares of AMICUS THERAPEUTICS INC (FOLD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James E. Dentzer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James E. Dentzer has 40 Form 4 filings on record as an insider at AMICUS THERAPEUTICS INC.
Set alerts for James E. Dentzer and 40,000+ other insiders.